Epitomee Medical to Present Groundbreaking Results at ObesityWeek® 2024 Conference in Texas!
We are thrilled to announce that Epitomee Medical intends to present the pivotal results of the RESET study at the upcoming ObesityWeek® 2024, one of the most prestigious global conferences focused on obesity science and treatment. The event will take place in San Antonio, Texas from November 3-6, 2024.
Our oral presentation, titled “Randomized Double-Blind Placebo-Controlled Study of a Novel Oral Hydrogel Capsule for Weight Loss,” will be presented by Professor Jamy Ard on November 6th at 9:15 AM (CT). Professor Ard, an esteemed leader in obesity research and President-Elect of The Obesity Society (TOS), led the RESET study as Principal Investigator.
The Obesity Society (TOS) is a leading organization dedicated to obesity science, treatment, and prevention. With over 2,800 members worldwide, TOS brings together clinicians, researchers and educators who are committed to advancing the understanding and management of obesity. ObesityWeek® is TOS’s premier annual event, featuring cutting-edge research, clinical applications, and policy discussions aimed at improving obesity care and prevention.
The Epitomee® Capsule offers a unique, drug-free alternative to current treatments, using a cutting-edge ingestible medical device designed to support weight management and demonstrating effective and safe weight loss. Key results from the study, which helped secure FDA clearance, demonstrate:
- Significant weight loss compared to placebo (P<0.0001)
- High retention rates with a favorable safety profile
- Positive impact on health markers and quality of life improvements
This is a pivotal moment for Epitomee and the wider medical community. Our mission is to make weight management solutions more accessible, offering new hope for individuals with a BMI of 25-40 who seek easy-to-use, tolerable options for long-term success.
Join us at ObesityWeek® 2024 to learn more about this exciting development and how we’re transforming the future of Over-weight and obesity treatment.
